Skip to main content

Table 1 Overview of important model parameters

From: Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening

Variable

Base-case analysis

Sensitivity analysis

Reference

FIT-screening

  

National monitor of the Dutch CRC screening program [29, 34]

 Participation FIT

0.73

 

 Adherence to FIT-positive colonoscopy

0.92

 

 Adherence to surveillance colonoscopy

0.92

 

Primary colonoscopy screening

  

[27, 29]

 Adherence to screening colonoscopy

 

0.22

 Adherence to surveillance colonoscopy

 

0.92

FIT positivity rate per lesion

Men

Women

Men

Women

[31]

 Healthy

0.96a

0.97a

   

 Diminutive adenoma

0.004

0.003

   

 Small adenoma

0.12

0.10

   

 Large adenoma

0.30

0.28

   

 Small SP

0.004

0.003

0.06

0.05

 

 Large SP

0.004

0.003

0.30

0.28

 

 Early stage CRC

0.50

0.50

   

 Late stage CRC

0.85

0.85

   

Contribution of serrated pathway to CRC incidence

15%

 

30%

 

[12]

Complications after colonoscopy

0.0028

   

[35,36,37]

Fatal complications after colonoscopy

0.0001

   

[35,36,37]

  1. FIT, fecal immunochemical test
  2. aSpecificity per individual